Maslinic Acid Suppresses High Glucose-induced Inflammation by Epigenetically Inhibiting TXNIP Expression

Abstract

Objective

Hyperglycemia-induced inflammation and subsequent endothelial injuries ultimately lead to the pathogenesis of cardiovascular diseases associated with high mortality, such as atherosclerosis. Maslinic acid (MA) is a phytochemical with anti-inflammatory activity. However, it remains unknown whether it can inhibit diabetes-associated cardiovascular inflammation. The present study aimed to determine the effect of MA on high glucose-induced endothelial inflammation and apoptosis in human umbilical vein endothelial cells (HUVECs) and to explore the underlying mechanism.

Methods

HUVECs were treated with high glucose to induce inflammation and apoptosis. Apoptosis was determined by flow cytometry. CCK-8 assay was used to examine cell viability. Production levels of cytokines were detected by quantitative realtime PCR (qPCR) and ELISA. Protein expression levels and signaling pathways activation were detected by Western blotting. RNA immunoprecipitation and qPCR were used to determine the N⁶-methyladenosine (m6A) levels of target mRNAs.

Results

MA promoted the recruitment of RNA demethylase ALKBH5 to TXNIP mRNA, and subsequently enhanced its m6A demethylation. By this means, MA decreased the stability of TXNIP mRNA and downregulated its expression level. Subsequently, reactive oxygen species (ROS) and production of pro-inflammatory cytokines, including TNF-α, IL-6 and IL-1β, were inhibited. And high glucose-induced apoptosis in HUVECs was inhibited by MA.

Conclusion

MA ameliorates high glucose-induced endothelial inflammation and injury, serving as a new potential therapeutic application for protecting against diabetes-associated atherosclerosis and other inflammatory diseases.

Keywords

maslinic acid / inflammation / N⁶-methyladenosine / RNA demethylase ALKBH5

References

[1] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390(10100): 1211-1259

[2] KharroubiAT, DarwishHM. Diabetes mellitus: The epidemic of the century. World J Diabetes, 2015, 6(6): 850-867

[3] TalebS. Inflammation in atherosclerosis. Arch Cardiovasc Dis, 2016, 109(12): 708-715

[4] AbubakarA, NazifiAB, MajeIM, et al.. Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-γ and dipeptidyl peptidase-4. J Integr Med, 2021, 19(1): 78-84

[5] SariY, AnamA, SumeruA, et al.. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. J Integr Med, 2021, 19(4): 347-353

[6] ZhangM, YeM. Hydrogen Sulfide Attenuates High Glucose-induced Myocardial Injury in Rat Cardiomyocytes by Suppressing Wnt/beta-catenin Pathway. Curr Med Sci, 2019, 39(6): 938-946

[7] GaoH, DuWY, LinJ, et al.. Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression. Curr Med Sci, 2021, 41(3): 505-512

[8] DubeyR, PrabhakarPK, GuptaJ. Epigenetics: key to improve delayed wound healing in type 2 diabetes. Mol Cell Biochem, 2022, 477(2): 371-383

[9] KingJ, PatelM, ChandrasekaranS. Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective. Metabolites, 2021, 11(11): 792

[10] TongJ, FlavellRA, LiHB. RNA m(6)A modification and its function in diseases. Front Med, 2018, 12(4): 481-489

[11] ZhangC, ChenY, SunB, et al.. m(6)A modulates haematopoietic stem and progenitor cell specification. Nature, 2017, 549(7671): 273-276

[12] HanB, YaoHH. N(6)-methyladenosine as a Novel Regulator of Brain Physiology and Diseases. Curr Med Sci, 2020, 40(3): 401-406

[13] LiuJ, EckertMA, HaradaBT, et al.. m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol, 2018, 20(9): 1074-1083

[14] MathiyalaganP, AdamiakM, MayourianJ, et al.. FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. Circulation, 2019, 139(4): 518-532

[15] WuY, XieL, WangM, et al.. Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun, 2018, 9(1): 4772

[16] ChenM, LinW, YiJ, et al.. Exploring the Epigenetic Regulatory Role of m6A-Associated SNPs in Type 2 Diabetes Pathogenesis. Pharmgenomics Pers Med, 2021, 14: 1369-1378

[17] LiangD, LinWJ, RenM, et al.. m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy, 2022, 18(6): 1318-1337

[18] YapWH, OoiBK, AhmedN, et al.. Maslinic acid modulates secreted phospholipase A2-IIA (sPLA2-IIA)-mediated inflammatory effects in macrophage foam cells formation. J Biosci, 2018, 43(2): 277-285

[19] AmpofoE, BergJJ, MengerMD, et al.. Maslinic acid alleviates ischemia/reperfusion-induced inflammation by downregulation of NFκB-mediated adhesion molecule expression. Sci Rep, 2019, 9(1): 6119

[20] ChenYL, YanDY, WuC, et al.. Maslinic acid prevents IL-1β-induced inflammatory response in osteoarthritis via PI3K/AKT/NF-κB pathways. J Cell Physiol, 2021, 236(3): 1939-1949

[21] WeiQ, ZhangB, LiP, et al.. Maslinic Acid Inhibits Colon Tumorigenesis by the AMPK-mTOR Signaling Pathway. J Agric Food Chem, 2019, 67(15): 4259-427

[22] XuJ, ChenY, XingY, et al.. Metformin inhibits high glucose-induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1-FOXO1-autophagy axis. Clin Exp Pharmacol Physiol, 2019, 46(9): 813-820

[23] FloryJ, LipskaK. Metformin in 2019. Jama, 2019, 321(19): 1926-1927

[24] PanahiG, PasalarP, ZareM, et al.. High glucose induces inflammatory responses in HepG2 cells via the oxidative stress-mediated activation of NF-κB, and MAPK pathways in HepG2 cells. Arch Physiol Biochem, 2018, 124(5): 468-474

[25] DeviTS, HosoyaK, TerasakiT, et al.. Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy. Exp Cell Res, 2013, 319(7): 1001-1012

[26] HongSY, HagenT. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation — Implications for targeting the Warburg effect in cancer cells. Biochem Bioph Res Co, 2015, 465(4): 838-844

[27] WuN, ZhengB, ShaywitzA, et al.. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell, 2013, 49(6): 1167-1175

[28] KelleherZT, WangC, ForresterMT, et al.. ERK-dependent proteasome degradation of Txnip regulates thioredoxin oxidoreductase activity. J Biol Chem, 2019, 294(36): 13336-13343

[29] MeyerKD, PatilDP, ZhouJ, et al.. 5′ UTR m(6)A Promotes Cap-Independent Translation. Cell, 2015, 163(4): 999-1010

[30] WangX, LuZ, GomezA, et al.. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature, 2014, 505(7481): 117-120

[31] WangX, ZhaoBS, RoundtreeIA, et al.. N(6)-methy-ladenosine Modulates Messenger RNA Translation Efficiency. Cell, 2015, 161(6): 1388-1399

[32] JiaG, FuY, ZhaoX, et al.. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol, 2011, 7(12): 885-887

[33] ZhengG, DahlJA, NiuY, et al.. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cello, 2013, 49(1): 18-29

[34] MedzhitovR. Origin and physiological roles of inflammation. Nature, 2008, 454(7203): 428-435

[35] BetrainsA, StaelsF, SchrijversR, et al.. Systemic autoinflammatory disease in adults. Autoimmun Rev, 2021, 20(4): 102774

[36] WolfD, LeyK. Immunity and Inflammation in Atherosclerosis. Circ Res, 2019, 124(2): 315-327

[37] SoehnleinO, LibbyP. Targeting inflammation in atherosclerosis — from experimental insights to the clinic. Nat Rev Drug Discov, 2021, 20(8): 589-610

[38] ZhangQ, CaoX. Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol, 2019, 19(7): 417-432

[39] YangC, HuY, ZhouB, et al.. The role of m(6)A modification in physiology and disease. Cell Death Dis, 2020, 11(11): 960

[40] JainR, GroverA. Maslinic acid differentially exploits the MAPK pathway in estrogen-positive and triple-negative breast cancer to induce mitochondrion-mediated, caspase-independent apoptosis. Apoptosis, 2020, 25(11–12): 817-834